Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Fed Preview: July meeting may disappoint doves, Powell will only give preliminary hints of a rate cut in September

Fed Preview: July meeting may disappoint doves, Powell will only give preliminary hints of a rate cut in September

Bitget2024/07/30 02:18

The market has fully priced in the Federal Reserve's rate cut in September, but a big question for the FOMC meeting from July 30 to 31 is: How clear will the FOMC signal be?

Foreign media economists such as Anna Wong believe that communication at the July meeting will only provide an initial hint of a rate cut in September. Fed Chairman Powell will point out that "if data develops as we expect", there may be a rate cut. Economists believe that the main reason for hesitation is simply that there are still plenty of data to be released before the FOMC meeting on September 17-18 - two inflation and employment reports are due before then, and data could change significantly. The best time to clearly hint at a September rate cut would be Powell's speech at Jackson Hole Central Bank Annual Meeting at the end of August, by which time he would have another month's worth of employment and inflation data.

Economists' expectations for the FOMC meeting from July 30 to 31 are: Despite many Wall Street analysts calling for interest cuts, it is expected that FOMC will unanimously decide to keep rates unchanged between 5.25% -5.50%. Inflation data since June’s FOMC meeting has been encouraging while economic activity data has been slightly worrying. Overall, it is likely that committee believes risks balance roughly equally between its two goals—price stability and full employment.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

From $617 to $350: CVS Sets "Break-Even Price" for Weight-Loss Drugs, Says Pharmaceutical Companies Can Still Profit

An analysis of insurance claims data found that if GLP-1 drugs used for weight loss and diabetes are priced below $350 per month, payers—such as employers and plan sponsors—would achieve net savings due to a decrease in related healthcare service utilization.

智通财经•2026/11/15 04:01
From $617 to $350: CVS Sets "Break-Even Price" for Weight-Loss Drugs, Says Pharmaceutical Companies Can Still Profit